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Introduction
Cavernous malformations (CMs) account for 5% to 15%
of all central nervous system (CNS) vascular malformations.
Brainstem cavernous malformations (BCMs) are rare, and
9% to 35% of all CMs are located in the brainstem.5)6)9)11)16)
Because of their eloquent location, BCMs can result in
hemorrhages, progressive neurological deficits, and fatal
outcomes, such as death.4)14) Due to their precarious location
and potentially devastating clinical course, BCMs are
particularly challenging for neurosurgeons.7) With the
improvements in neuroimaging and microsurgical
techniques, surgeons no longer consider BCMs inoperable.19)
However, most BCMs have limited surgical indications and
a considerable rate of surgical morbidity.
Surgeons should consider treating BCMs via surgical
resection, given an appropriate clinical scenario. Patients
who have had recurrent hemorrhages or who are
experiencing progressive neurological decline should have
the option of surgery. It is also reasonable to consider
observation for patients with previous hemorrhagic episodes
and acceptable neurological deficits. 7) BCMs have a
propensity for hemorrhage and re-hemorrhage. The
incidence of hemorrhage and re-hemorrhage for BCMs is
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20-fold higher than that of supratentorial cavernous
malformations is.2)8)17) Therefore, a BCM requires a prudent
surgical decision.
We performed this retrospective clinical analysis on 15
patients that our hospital treated operatively for BCMs,
between 1989 and 2010. We describe the immediate and
long-term surgical outcomes, complications, and surgical
indications, including locations of lesions, surgical
approaches, and surgery time.
Materials and Methods
1. Patients and clinical characteristics
We retrospectively analyzed clinical data of 15 patients
who underwent microsurgical treatment for BCMs at our
institution between August 1989 and March 2010. Table 1
summarizes the patients' clinical characteristics. All patients
presented with at least one hemorrhagic episode at the time
of their admission. Clinical presentations of all patients
included hemiparesis, hemihypesthesia, ataxia, dizziness,
nausea, vomiting, diplopia, dysphagia, signs of increased
intracranial pressure (ICP), and cranial nerve (CN) palsies.
In particular, we investigated the CN palsies in numerical
order, from the third to the ninth CN. The clinical
presentations differed according to the lesions’ locations
(Table 2). The anatomical locations of the lesions were
defined via magnetic resonance imaging (MRI) and
classified as follows: midbrain, pons-midbrain, pons, pons-
medulla, and medulla oblongata. 
MRI scans were obtained for all patients. Surgeons did not
perform cerebral angiographies when MRI showed patients
with typical features of cavernous malformations.
Angiography generally reveals no definite abnormal vascular
structures, except coexisting venous anomalies. The typical
MRI findings were “popcorn” or “mulberry” lesions from
previous, recurrent hemorrhages.19) In each case, we
measured the maximal diameter of the lesion on the
preoperative MRI and also evaluated whether the lesion
reached the pial surface of the brainstem or not. We defined
lesions that reached the pial surface as “exophytic.” Lesions
that were not visible upon initial exposure we termed
“intrinsic.”8) We recorded intra-operative findings based on
the operative reports. Each patient had received a diagnosis
of cavernous malformation by means of a postoperative
histopathologic examination. 
Patients were observed for a mean period of 53.1 months
(range 1-131 months) after their diagnosis (nine patients >
24 months' follow-up). During the follow-up period, three
patients were lost to the follow-up; also, one patient expired,
due to aspiration pneumonia, 31 months postoperatively.
Eleven patients completed follow-up and received 
evaluations comprising neurological examinations and
postoperative imaging studies at the outpatient department or
telephone interviews.
2.  Surgical approaches
In each case, we had selected the surgical approaches
based on the CMs’ locations and the nearest site at which the
hemorrhages presented to the pial or ependymal surfaces.
We had also considered the location of the safe entry zone
into each patient’s brainstem for the optimal surgical
approaches and had performed a midline suboccipital
approach for any lesion located in the dorsal pontine or
medulla oblongata, also using this approach, when
appropriate, to explore the lesion through the fourth ventricle
floor. When we approached the CM through the floor of the
fourth ventricle, we accessed the lesion through either the
upper-facial triangle or the lower-facial triangle, to minimize
dissection and retraction of brainstem tissue.1)13)19) For lesions
involving the inferior portion of the middle cerebellar
peduncle, we resected them via a telovelar approach (which
is the same as a transcerebello-medullary fissure approach).7)
We resected cavernous malformations involving the
midbrain's tectum or lateral surface through the occipital
transtentorial approach. Patients with lesions in the
anterolateral surface of the pons or the lateral surface of the
midbrain underwent surgeries using a subtemporal approach
or a transpetrosal approach. For infants, we used the
transcortical transforaminal approach for any midbrain
lesion presenting as postoperative recurrent hemorrhage.
Table 1 and Table 3 summarize the surgical approaches we
used in our series.
The aim of these surgeries was total resection of the CMs
while minimizing damage to the brainstem. During each
surgery, we first opened the hematoma wall and then
removed the hematoma. Usually we dissected the hematoma
together with the malformed vessel. A yellowish
hemosiderin-stained layer around the hematoma is a helpful
Surgical Outcomes of Brainstem Cavernous Malformations
170 Kor J Cerebrovascular Surgery 12(3):169-176, 2010
Byeong Woo Kim∙ Jae Whan Lee∙Seung Kon Huh∙ Kyu Chang Lee
171Kor J Cerebrovascular Surgery 12(3):169-176, 2010
Ta
b
le
 1
. S
um
m
ar
y 
of
 p
at
ie
nt
s 
wi
th
 b
ra
in
ste
m
 c
av
er
no
us
 m
al
fo
rm
at
io
ns
: c
lin
ic
al
 c
ha
ra
ct
er
ist
ic
s, 
po
sto
pe
ra
tiv
e 
ou
tc
om
es
, s
ur
gi
ca
l a
pp
ro
ac
he
s, 
an
d 
co
m
pl
ic
at
io
ns
.
No
.
Se
x
Ag
e
C
hi
ef
 c
om
pl
ai
ns
No
. o
f
Lo
ca
tio
n
O
p.
 a
pp
ro
ac
h
In
tri
ns
ic
 /
Pr
eo
p.
Po
sto
p.
Tim
e 
of
C
om
pl
ic
at
io
ns
 
F/U
 
he
m
or
rh
ag
e 
  
Ex
op
hy
tic
   
KP
S 
  
KP
S 
   
su
rg
er
y
(m
on
th
s)
1
F
47
Lt.
 h
em
ip
ar
es
is
3
M
ed
ul
la
Su
bo
cc
ip
ita
l
In
tri
ns
ic
40
15
no
ne
�
lo
ss
2
F
36
Rt
. h
em
ip
ar
es
is
1
Po
ns
Su
bt
em
po
ra
l
In
tri
ns
ic
60
16
no
ne
�
lo
ss
3
F
51
Lt.
 h
em
ip
ar
es
is,
 d
ip
lo
pi
a,
1
Po
ns
, 
Su
bo
cc
ip
ita
l
In
tri
ns
ic
30
4
no
ne
�
lo
ss
Lt.
 fa
ci
al
 w
ea
kn
es
s, 
IIC
P*
 S
x
M
id
br
ai
n
4
F
5
Lt.
 h
em
ip
ar
es
is,
 d
ip
lo
pi
a,
 IIC
P*
 S
x
3
M
id
br
ai
n
Su
pr
ac
er
eb
el
la
r
In
tri
ns
ic
20
90
26
no
ne
�
13
1
5
M
35
IIC
P*
 S
x
3
M
ed
ul
la
Su
bo
cc
ip
ita
l
In
tri
ns
ic
30
90
4
no
ne
�
99
6
F
41
Lt.
 h
em
ip
ar
es
is,
 d
ip
lo
pi
a
1
Po
ns
, 
Su
bo
cc
ip
ita
l
Ex
op
hy
tic
30
80
51
Rt
. F
ac
ia
l p
al
sy
77
M
id
br
ai
n
7
F
35
Lt.
 h
em
ip
ar
es
is,
 d
ip
lo
pi
a,
 IIC
P*
 S
x
1
Po
ns
Su
bo
cc
ip
ita
l
In
tri
ns
ic
30
80
19
Rt
. F
ac
ia
l p
al
sy
76
8
M
48
Di
pl
op
ia
, L
t. 
fa
ci
al
 w
ea
kn
es
s
2
Po
ns
Tra
ns
pe
tro
sa
l
nt
rin
sic
40
30
14
Dy
sp
ha
gi
a,
 q
ua
dr
ip
ar
es
is,
40
Re
sp
ira
to
ry
 d
iffi
cu
lty
(tr
ac
he
os
to
m
y)
9
F
58
Di
pl
op
ia
1
M
id
br
ai
n
O
cc
ip
ita
l 
nt
rin
sic
80
50
1 
yr
Re
cu
rre
nt
 h
em
or
rh
ag
es
�
35
tra
ns
te
nt
or
ia
l 
Lt.
 3
rd
 C
N 
pa
lsy
,
Rt
. h
em
ip
ar
es
is
10
F
38
Rt
. h
em
ip
ar
es
is,
 d
ip
lo
pi
a,
 
2
Po
ns
, 
Su
bo
cc
ip
ita
l
Ex
op
hy
tic
30
50
11
no
ne
�
1
Rt
. f
ac
ia
l w
ea
kn
es
s, 
dy
sp
ha
gi
a
M
id
br
ai
n
11
M
3
Rt
. h
em
ip
ar
es
is,
 d
ip
lo
pi
a,
 
2
M
id
br
ai
n
O
cc
ip
ita
l 
In
tri
ns
ic
40
0
Re
cu
rre
nt
 h
em
or
rh
ge
s§
Ex
pi
re
d
IIC
P*
 S
x  
tra
ns
te
nt
or
ia
l 
Rt
. 3
rd
 C
N 
pa
lsy
,
hy
dr
oc
ep
ha
lu
s, 
dy
sk
in
et
ic
 in
vo
lu
nt
ar
y 
m
ov
em
en
t
12
M
29
Di
pl
op
ia
, R
t. 
fa
ci
al
 w
ea
kn
es
s
2
Po
ns
, 
Su
bo
cc
ip
ita
l
Ex
op
hy
tic
80
90
35
no
ne
�
11
M
ed
ul
la
13
M
67
Rt
 h
em
ip
ar
es
is,
 d
ip
lo
pi
a,
 
2
Po
ns
Su
bo
cc
ip
ita
l
In
tri
ns
ic
60
40
16
Dy
sp
ha
gi
a,
 q
ua
dr
ip
ar
es
is,
38
Lt.
 fa
ci
al
 w
ea
kn
es
s 
re
sp
.d
iffi
cu
lty
 (t
ra
ch
eo
sto
m
y)
14
M
48
Di
pl
op
ia
, L
t. 
fa
ci
al
 w
ea
kn
es
s
2
Po
ns
, 
Su
bo
cc
ip
ita
l
Ex
op
hy
tic
60
70
12
He
m
ih
yp
es
th
es
ia
, 
51
M
ed
ul
la
  
de
cr
ea
se
d 
to
ng
ue
 se
ns
e,
 
Po
sto
p.
 ED
**
15
M
46
Bo
th
 h
an
d 
nu
m
bn
es
s &
 p
ai
n
1
M
ed
ul
la
Su
bo
cc
ip
ita
l
Ex
op
hy
tic
90
70
31
Q
ua
dr
ip
ar
es
is
25
vo
id
in
g 
di
ffic
ul
ty
 
Rt
., 
Rig
ht
; L
t.,
 Le
ft;
 N
o,
 N
um
be
rs;
 O
p.
, O
pe
ra
tiv
e;
 P
re
op
., 
Pr
eo
pe
ra
tiv
e;
 P
os
to
p.
, P
os
to
pe
ra
tiv
e;
 K
PS
, K
ar
no
fsk
y 
Pe
rfo
rm
an
ce
 S
ca
le
; F
/U
, F
ol
lo
w-
up
 
* 
IIC
P 
=
 In
cr
ea
se
d 
in
tra
cr
an
ia
l p
re
ss
ur
e
�
No
 c
ha
ng
e 
or
 tr
an
sie
nt
 a
gg
ra
va
tio
n 
of
 p
re
ex
ist
in
g 
ne
ur
ol
og
ic
al
 d
ef
ic
it
�
Th
e 
pa
tie
nt
 su
ffe
re
d 
re
cu
rre
nt
 h
em
or
rh
ag
es
 tw
ic
e 
po
sto
pe
ra
tiv
el
y,
 b
ec
au
se
 o
f s
ub
to
ta
l r
es
ec
tio
n.
§T
he
 p
at
ie
nt
 su
ffe
re
d 
re
cu
rre
nt
 h
em
or
rh
ag
es
 th
re
e 
tim
es
 p
os
to
pe
ra
tiv
el
y,
 b
ec
au
se
 o
f s
ub
to
ta
l r
es
ec
tio
n.
**
Im
m
ed
ia
te
 p
os
to
pe
ra
tiv
e 
ep
id
ur
al
 h
em
at
om
a
guide for surgical resection.19) We used neuronavigation for
identifying the location of the hematoma and repeated
electrophysiological stimulation of the resection bed and
floor of the fourth ventricle to confirm preservation of
brainstem nuclei.14) We usually carried out intraoperative
monitoring of somatosensory evoked potentials, brainstem
auditory evoked potentials, and facial electromyography
(EMG) in these cases.
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Table 2. Clinical presentations according to the brainstem cavernous malformations' locations
Signs & symptoms Midbrain
Pons- Pons- Medulla
(3) Midbrain Pons (4) Medulla (3)
(3) (2)
Hemiparesis 2 3 3 1
Hemihypesthesia 2 1
Ataxia 1 1 1
Dizziness 2 1 2 1
Nausea / vomitng 2 1 1 1
Diplopia 3 3 3
Hand numbness 1
CN 3 palsy 3 2
CN 4 palsy
CN 5 palsy 2
CN 6 palsy 3 3 2
CN 7 palsy 2 2 2
CN 8 palsy 1 1
CN 9 palsy 2
Dysphagia 2
IICP* symptoms 2 1 1 1
**IICP = Increased intracranial pressure
Table 3. Summary of the surgical approaches for brainstem cavernous malformations (15 patients, 18 operations, including re-
operations for recurrent hemorrhages)
Locations of the lesions
Surgical approaches Total Midbrain Pons-midbrain Pons Pons-medulla Medulla
Midline Suboccipital 10 3 2 2 3
Telovelar app. 5 1 2 2
Transvermian app. 2 2
Others 3 3
Subtemporal 1 1
Transpetrosal 1 1
Occipital 4 4
transtentorial�
Supracerebellar 1 1
infratentorial
Transcortical 1
transforaminal�
�Including two re-operations
�Including one re-operation
3.  Clinical outcomes
To evaluate clinical outcomes, we used Karnofsky
Performance Scale (KPS) scores. Preoperative KPS scores
ranged from 20 to 90. The final 11 patients completed
follow-up (9 patients > 24 months follow-up), and we
obtained follow-up data by means of telephone interviews
and/or outpatient clinic visits. Patients were asked if they
were “the same”, “better”, or “worse,” compared to their
preoperative statuses. We used the KPS score to provide an
objective measurement of the patients’ preoperative and
postoperative neurological statuses. We defined “poor
outcome” as a KPS score lower than 60 on last follow-up,
which was more than 1 month after surgery or initial
evaluation. We also investigated their complications,
including any newly-developed postoperative neurological
deficit, recurrent hemorrhagic rates, and surgery-related
complications, such as postoperative epidural hematoma.
We summarized the clinical outcomes using the following
parameters: surgical approach according to the location of
the lesion, timing of surgery, KPS score, surgery related
complications, recurrent hemorrhagic rates, and whether the
patient underwent a total resection or not. Table 1
summarizes these parameters.
Results
1.  Patient characteristics and clinical presentations
All 15 patients received microsurgery for evacuation of a
hematoma and extirpation of a CM. There were 7 males and
8 females, and the mean age was 39.1 years (range, 3-67
years old). Most patients had presented with a hemorrhage at
the time of admission; 6 patients had experienced 1
hemorrhage episode, while 9 patients had experienced 2 or
more before surgery. There were 5 patients (33%) with
exophytic lesions, and the rest had intrinsic lesions. We
found multiple lesions in 2 patients (13.3%).
We categorized the patients according to the location(s) of
their CM(s) as follows: midbrain, pons-midbrain, pons,
pons-medulla, and medulla oblongata. There were 3 patients
with lesions in the midbrain (20%), 3 with lesions in the
pons-midbrain (20%), 4 lesions in the pons (26.7%), 2, in the
pons-medulla (13.3%), and 3 in the medulla oblongata
(20%). Most patients (87%) presented with sudden-onset
symptoms. At the time of their initial presentation, we
observed hemiparesis in 9 patients (60%), diplopia in 11
patients (73.3%), facial weakness in 6 (40%), and increased
ICP Symptoms in 5 (33.3%). Only 1 patient had numbness
and pain in both hands. The clinical presentations differed
according to the locations of the lesions (Table 2).
Hemiparesis and diplopia were the most common
presentations, occurring in all groups. All patients in the
midbrain group suffered diplopia, defined as oculomotor
nerve palsy. Most lesions involving the pons had various CN
palsies; 8 patients with pons lesions (pons-midbrain, pons,
and pons-medulla) presented with sixth CN palsy, and 6 with
lesions in any of these pons categories presented with
seventh CN palsy. Also, 2 of the 3 patients with a lesion in
the midbrain presented with symptoms of increased ICP. 
2.  Surgical approaches
All 15 patients underwent microsurgery. For the 10
patients with CMs in a medulla or a pons category, we used
a midline suboccipital approach. However, we used the
telovelar approach for 5 such patients, because their lesions
were close to the fourth ventricle floor. For 2 patients with
huge hematomas in the pons-midbrain, we used the
transvermian approach. For 2 patients whose CMs presented
on the lateral or anterolateral surface of the midbrain, we
used the occipital transtentorial approach. However, both
patients had re-operations for postoperative recurrent
hemorrhage. Of the 2 surgically treated for recurrent
hemorrhage, 1 underwent surgeries using the same approach
(occipital transtentorial) twice postoperatively, and the other
underwent the transcortical transforaminal approach for a
lesion on the anterolateral surface of the midbrain. One
patient with a lesion in the posterior midbrain underwent
surgery using the supracerebellar-infratentorial approach, 1
patient with the lesion on the anterolateral surface of the
pons underwent surgery using the subtemporal approach,
and one patient with the lesion in the lateral surface of the
pons underwent surgery using the posterior transpetrosal
approach.
3.  Clinical outcomes
We could give the complete follow-up to 11 of the 15
patients. The mean follow-up period was 53.1 months (range
1-131 months) after diagnosis (9 patients > 24 months
follow-up). There were 3 patients lost to follow-up, and 1
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patient expired, due to aspiration pneumonia, 31 months
postoperatively. The expired patient’s condition remained
the same compared to his preoperative condition (KPS score
of 40). The mean preoperative KPS score was 50, and the
mean postoperative KPS score was 67. During the complete
follow-up period, 3 patients recovered completely (KPS
scores of 90-100) and resumed daily activities, while 2
patients could perform normal activities with effort (KPS
scores of 80). Another 2 patients could care for themselves
but were unable to return to work (KPS scores of 70).
Mostly, the patients' neurological statuses were better than
before surgery. Of the 11 patients (63.6%) with complete
follow-up, 7 had higher KPS scores, while 4 patients
ultimately had poor postoperative scores. Of these 4, 2
needed considerable assistance (KPS scores of 50), another
patient required special medical care (KPS score of 40) and
the remaining 1 was severely disabled (KPS score of 30).
The last 2 patients (KPS scores of 30-40) were hospitalized
at a rehabilitation center.
Thirteen of 15 patients successfully underwent total
resection of CMs, while 2 patients underwent partial
resections of their lesions and suffered postoperative
recurrent hemorrhages. Both of them had lesions in the
midbrain and underwent surgeries that used the occipital
transtentorial approach. One of the 2 suffered recurrent
hemorrhage 20 months postoperative and underwent re-
operation via the transcortical transforaminal approach. The
other patient underwent re-operation twice, via the occipital
transtentorial approach both times. Both of these patients
finally underwent total resection of CMs and suffered no
more recurrent hemorrhages postoperatively (Fig. 1-B, C).
We observed various postoperative complications. One
patient with deteriorated mentality underwent re-operation
for postoperative epidural hematoma and immediately
experienced an improvement in symptoms. At 1 month after
surgery, all 15 patients underwent follow-up examinations to
determent their postoperative statuses. Seven of them had no
newly developed complications or aggravations of the
preexisting neurological deficits. Six patients suffered
newly-appearing incomplete CN palsies or aggravation of
their previous symptoms. At present, 4 of them have
experienced improved symptoms. However, the other 2 have
suffered from quadriparesis, respiration difficulties, and
severe dysphagia. These severely disabled patients
underwent tracheostomies and needed gastric tubes for
feeding.    
Discussion
Cavernous malformations are uncommon congenital
vascular anomalies of the brain. Their characteristics include
having sinusoidal vascular spaces in-between one another,
with no intervening brain parenchyma, and occurance in any
part of the central nervous system.14) CMs have a significant
risk of intracranial hemorrhages. In particular, a brainstem
cavernous malformation can present with progressive
neurological decline and result in neurological mortality and
morbidity. Each CM has a different hemorrhagic rate,
Surgical Outcomes of Brainstem Cavernous Malformations
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Fig. 1. A 58-year-old female with a brainstem cavernous malformation underwent subtotal resection of cavernous malformations
and suffered recurrent hemorrhages twice postoperatively. (A) Preoperative T2 weighted MR image shows a chronic hemorrhagic cyst
in the midbrain. (B) Axial non-contrast CT scan shows a postoperative recurrent hemorrhage. (C) Postoperative T2 FLAIR image shows
total resection of the cavernous malformation. The patient suffered no more recurrent hemorrhage postoperatively.
depending on its intracranial location. BCMs have a 20-
times greater hemorrhage and re-hemorrhage rate than do
supratentorial lesions.2)8)17) Wang et al. reported that the
BCMs' annual bleeding rate was 6%, higher than that of
CMs in other intracranial locations.19) Generally, the
estimated risk of hemorrhage from BCM is about 0.7% to
6.0% per year, per lesion. The recurrent hemorrhagic rate is
about 5% to 30% per year per lesion.3)8)10)17)19) The risk of
recurrent hemorrhage is higher for the familial type,
infratentorial lesions, deep lesions, and lesions with previous
hemorrhage.2)11)12)17) In our study, 9 of 15 patients (60%)
suffered hemorrhagic episodes 2 or more times before their
surgeries. 
Most patients (87%) presented with sudden-onset
symptoms and experienced various forms of CNS deficit.
Manifestation of CN deficit was decided by the location of
lesions. We reported that the lesion involving the pons had
multiple CN deficits. With conservative treatment, the
patient’s neurological deficit usually improves, but BCMs
are very likely to re-bleed, resulting in new or more
pronounced neurological deficits. Wang et al. described this
“relapsing and remitting” history and reported that patients’
neurological deficits became more pronounced and
permanent.19) Garrett et al. suggested considering surgical
resection of the lesion, given the appropriate clinical
scenario.7)
Most authors recommended surgery for symptomatic and
accessible lesions. In this study, we considered surgery for
patents with progressive neurological deficits or surgically
accessible lesions. Wang et al. suggested considering
surgery for BCMs if indications include any of the
following: (1) progressive neurological deficits; (2) grave
clinical presentations like coma and cardiac and respiratory
instability; (3) overt acute or subacute hemorrhage on MRI,
either inside or outside CMs, with a mass effect; or (4) either
the CM or the hematoma reaches < 2mm from the pial
surface.19) Many researchers, including Li et al., recommend
surgery for lesions with recurrent hemorrhage.14) In the cases
of asymptomatic lesions or obvious recent hemorrhagic
lesions without access to the pial surface of the brainstem, Li
et al. do not recommend surgery. In the current study, a
chronic hemorrhagic cystic lesion on MRI, with clinically
mild symptoms (KPS score of 80), was surgically accessible.
However, the surgical outcome was poor, and the patient
suffered postoperative morbidity. We suggest treating
patients with asymptomatic or mild neurological signs
conservatively because of surgery-related risks and possible
postoperative morbidity.
The most important factor in a successful postoperative
outcome is the total resection of the lesion. Many authors
emphasize the importance of total resection for CMs because
residual CMs tend to experience recurrent hemorrhage, with
considerable cumulative morbidity.18) In our series, 2 of 15
patients treated with microsurgery underwent subtotal
resection of their lesions at the time of their first surgeries.
Both patients suffered recurrent hemorrhage postoperatively
and experienced morbidity as a result. We at first thought the
recurrent hemorrhage was the result of an inappropriate
surgical approach. We had used the occipital transtentorial
approach on 1 of them. However, this approach was not
proper, because the lesion was in the anterolateral surface of
the midbrain. The inappropriate surgical approach limited
the operative field, which hampered successful total
resection of the lesion. 
Many authors consider that the timing of surgery is an
important factor for successful BCMs surgery . Unless
patients had severe neurological deterioration or showed
cardiorespiratory instability that requiring emergent
evacuation, we preferred to treat patients with steroids and
mannitol for a week or two intravenously, letting their
edema subside, and then proceeded with their microsurgery.
Most authors suggested this method for successfully
performing total resection of a hematoma and minimizing
the dissection and retraction of brainstem tissue. The
hematoma may become well-organized with the passage of
time. This may make it difficult to explore the margins of the
cavity and separate cavernous malformation tissue from
reactive gliotic tissue.14) In the case of a patient with a
chronic hemorrhagic cyst, we had trouble in dissecting the
lesion from the margin of cavernous malformations during
the surgery (Fig. 1A). We performed the surgeries between
10 and 25 days after each patient's last hemorrhage (mean,
15 days). Most authors reported that patients who had
surgery in the subacute hemorrhagic stage had better
postoperative outcomes than did those who had surgery at a
later stage.14)15)
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Conclusion
BCMs can cause recurrent hemorrhage, progressive
neurological deficits, and mortality. Surgeons should
consider microsurgical resection the treatment of choice
when a patient suffers progressive neurological decline. The
success of surgery is dependent on an accurate surgical
approach, the appropriate timing for surgery, and successful
total resection of the lesion. In addition, surgeons must
understand the complex anatomy of the brainstem and use a
well-informed surgical approach for this eloquent region.
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